Novel Coronavirus (SARS-CoV-2/COVID-19)
The AHA urged the Department of Health and Human Services to reinstate the COVID-19 Provider Relief Fund reporting requirements outlined in its June 19 FAQ that defined both expenses and lost revenues attributable to COVID-19.
The American Hospital Association asks the Secretary of Health and Human Services (HHS) to reinstate the COVID-19 Provider Relief Fund (PRF) reporting requirements outlined in your June 19 frequently asked question that defined both expenses and lost revenues attributable to COVID-19.
More than 200,000 of our friends, family members, fellow citizens and front-line workers have succumbed to COVID-19 since March. To put that in context, that’s approximately the same as the population of Salt Lake City, Utah.
The fourth in the series featured Dr. Estes joined by Dr. David W. Zaas, CEO of MUSC Health - Charleston Division and Chief Clinical Officer for MUSC Health, to discuss COVID-19’s impact on health trends and services in South Carolina. This episode was recorded on September 24, 2020.
In preparation for a COVID-19 and influenza double epidemic, hospitals and health systems are accelerating efforts to inform and engage people in their communities about preventive measures. Here are their stories.
A fourth-grade student wrote a heartfelt note thanking the many heroes at Nebraska Medicine for helping people and fighting “villain viruses.”
Butler Hospital, a psychiatric hospital in Rhode Island, shares encouragement and ideas for managing anxiety and stress during the pandemic.
As the U.S. continues its COVID-19 fight, the need for safe medical care unrelated to the pandemic is more important than ever.
The Centers for Medicare & Medicaid Services announced $165 million in supplemental funding to help 33 states participating in the Money Follows the Person Medicaid demonstration transition older adults and individuals with disabilities from long-term care facilities to home and community-based…
Two clinical trials launched in April to evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19 are expanding, the National Institutes of Health announced.